Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes

European Journal of Clinical Investigation

Volumn 35, Issue 10, 2005, Pages 627-634

  Abdallah, B M ^a   Beck Nielsen, H ^a   Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cortisone; Glucose uptake; HSD1; Insulin resistance; Myotubes; Type 2 diabetes

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CORTISONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOSE; HYDROCORTISONE; INSULIN; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA; UNCLASSIFIED DRUG; CELL RECEPTOR; DNA BINDING PROTEIN; LIVER X RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HORMONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; METABOLIC DISORDER; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SKELETAL MUSCLE; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MUSCLE CELL; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; CARBENOXOLONE; CORTISONE; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; MIDDLE AGED; MUSCLE FIBERS; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID;

EID: 26044458939     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01552.x     Document Type: Article

References (31)

1. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 1999;96:513-23.
2. Bjorntorp P, Rosmond R. Obesity and cortisol. Nutrition 2000;16:924-36.
3. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
4. Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 1998;83:757-60.
5. Bjorntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 1999;16:373-83.
6. Stulnig TM, Waldhäusl W. 11beta-Hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia 2004;47:1-11.
7. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localisation of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 1998;83:1325-35.
8. Tannin GM, Agarwal AK, Monder C. The human gene for 11 beta-hydroxysteroid dehydrogenase: structure, tissue distribution, and chromosomal localisation. J Biol Chem 1991;266:16653-8.
9. Stewart PM, Krozowski ZS. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm 1999;57:249-324.
10. Stewart PM, Whorwood CB, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. J Steroid Biochem Mol Biol 1995;55:465-71.
11. Smith RE, MaGuire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K et al. Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. J Clin Endocrinol Metab 1996;81:3244-8.
12. Suzuki T, Sasano H, Suzuki S, Hirasawa G, Takeyama J, Muramatsu Y et al. 11beta-Hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action. J Clin Endocrinol Metab 1998;83:4022-5.
13. Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ et al. Expression of type 2, 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 1998;83:4490-7.
14. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002;87:3330-6.
15. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86:1418-21.
16. Reynolds RM, Chapman KE, Seckl JR, Walker BR, McKeigue PM, Lithell HO. Skeletal muscle glucocorticoid receptor density and insulin resistance. JAMA 2002;287:2505-6.
17. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 2002;87:2701-5.
18. Livingstone DE, Kenyon CJ, Walker BR. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol 2000;167:533-9.
19. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-3.
20. Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 2002;51:1066-75.
21. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 1975;35:609-16.
22. Gaster M, Petersen I, Hojlund K, Poulsen P, Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 2002;51:921-7.
23. Gaster M, Kristensen SR, Beck-Nielsen H, Schroder HD. A cellular model system of differentiated human myotubes. APMIS 2001;109:735-44.
24. Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson JA. Liver X receptors down-regulate 11 beta-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 2002;51:2426-33.
25. Sun K, Myatt L. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts. Endocrinology 2003;144:5568-77.
26. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70.
27. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 1997;94:14924-9.
28. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276:41293-300.
29. Nosadini R, Del Prato S, Tiengo A, Valerio A, Muggeo M, Opocher G et al. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 1983;57:529-36.
30. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 1997;321(3):707-12.
31. Olefsky JM, Kimmerling G. Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci 1976;271:202-10.